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Abstract 
Objective: Epidemiological research in functional somatic disorders such as irritable bowel 
syndrome, fibromyalgia, chronic fatigue syndrome, and bodily distress syndrome and related 
conditions such as health (illness) anxiety is often based on self-reported questionnaires or layman 
interviews. This study presents and describes the Research Interview for Functional somatic 
Disorders  (RIFD) and provides first data regarding RIFD’s ability to identify cases with functional 
somatic disorders and health anxiety in a two-phase design following self-reported symptom 
questionnaires. Methods: RIFD was performed by phone by trained family physicians on a 
stratified subsample of 1590 adults from a Danish general population cohort (n=7493). Criterion 
validity was tested in a small preliminary test including 25 RIFD participants using Schedules of 
Clinical Assessment in Neuropsychiatry (SCAN), performed by a specialist in functional somatic 
disorders, as gold standard. Interrater reliability between interviewers was tested in 15 participants. 
Results: Compared with the comprehensive SCAN, preparation and conduction of RIFD were 
feasible and prompt. RIFD was well accepted by both interviewers and interviewees. RIFD 
identified cases with significantly more impairment than identified non-cases. Based on small 
preliminary tests, RIFD showed promising psychometric properties. Conclusion: RIFD was a 
feasible, well-accepted and promising instrument for use in large epidemiological studies. However, 
larger studies investigating its psychometric properties are needed. 
Keywords: functional somatic syndromes, functional somatic disorders, bodily distress, health 
anxiety, illness anxiety, schedules of clinical assessment in neuropsychiatry. 
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1. Introduction 
Persistent physical symptoms contribute greatly to the burden of disease worldwide (1,2). In cases 
where all or at least the vast majority of those symptoms are not attributable to any known 
conventionally-defined medical condition, patients may be diagnosed with a so-called functional 
somatic syndrome, e.g. irritable bowel syndrome (IBS), fibromyalgia (FM), and chronic fatigue 
syndrome (CFS) (2). Many other diagnostic labels are used, and recently the unifying research 
diagnosis bodily distress syndrome (BDS) has been introduced (2,3). The impairing conditions may 
be subsumed under the umbrella term “functional somatic disorders” having in common that we do 
not have any objective clinical or paraclinical tests to verify the diagnoses. Hence, the diagnoses are 
based on subjective symptom reports only combined with ruling out differential diagnoses with 
concurrent symptom patterns (1,4,5).  
The various diagnostic constructs under the heading of functional somatic disorders are based on 
three basic principles: 1) a focus on somatic symptoms or symptom patterns (e.g. IBS or BDS), 2) a 
focus on cognitions, emotions and behaviours related to the symptoms (e.g. Somatic Symptom 
Disorder in the Diagnostic and Statistical Manual for Mental Disorders (DSM-5)), and 3) a focus on 
an assumed cause of the symptoms (e.g. whiplash associated disorders (WAD) or multiple chemical 
sensitivity (MCS) (5).   
The approaches to identify individuals with functional somatic disorders in epidemiological reseach 
are several. First, an often used approach is to use questionnaires for case identification (6-11). 
Questionnaires have the advantage of being cost-effective, easy to distribute, having high reliability, 
and they are not influenced by an intermediary's understanding of disease. However, questionnaires 
may have a low validity as to distinguishing between functional somatic disorders and medical 
diseases with a concurrent symptom pattern, i.e. it is difficult – or even impossible – to rule out 
relevant differential diagnoses. An additional challenge is to delimitate individuals with clinically 
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relevant disorders from individuals with normal bodily reactions. This distinction is rather arbitrary 
when based on self-reported questionnaires only and makes identification of clinically relevant 
cases and the establishment of a research diagnosis uncertain (12).  A second approach is simply to 
ask a patient or study participant whether or not they have received a diagnosis of a functional 
somatic disorder by a doctor (13). However, clinical diagnoses have shown to be biased as 
regarding sex ratio (14) and general understanding of classification and conceptualization of disease 
(15). Structured diagnostic interviews conducted by trained layman or physicans constitute a third 
approach (16). Layman interviews may carry the same problems as questionnaires as medical 
knowledge is necessary to differentiate between medical conditions. Some studies have tried to 
overcome this by having physicians review the layman interviews and make the final diagnoses 
(17). Diagnostic interviews conducted by physicians seem more reliable due to their medical 
knowledge. A final and most optimal approach would be to combine a physician-rated interview 
with a clinical examination and review of medical records. While this may be a practical procedure 
in clinical studies, this approach is too expensive and time-consuming in epidemiological research. 
Moreover, it raises ethical questions regarding the deep knowledge the interviewer gets about a 
participant's medical history. 
The psychiatric interview Schedules of Clinical Assessment in Neuropsychiatry (SCAN) (18) is a 
comprehensive diagnostic interview developed for the assessment of mental disorders. In 
collaboration with the SCAN World Health Organization (WHO) working group,  the Research 
Clinic for Functional Disorders and Psychosomatics at Aarhus University Hospital, Denmark, has 
refined the section on physical health and functional somatic disorders. This version has been used 
in daily clinic and in research (19-25). However, SCAN is time-consuming and requires 
interviewers with both medical background and special training in SCAN interviewing (typically at 
least one week of training, followed by at least ten individual diagnostic interviews that are checked 
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for interrater reliability). Hence, to use SCAN in large-scale epidemiological studies would be a 
prohibitive task in terms of time spent, economy, and personnel. A shorter version of SCAN has 
been developed for clinical use and clinical studies, but this version does not cover functional 
somatic disorders (26).  
A condition associated with the functional somatic disorders is health (illness) anxiety (27) which 
constitutes individuals with long-lasting and interfering preoccupation of having a serious illness 
despite repeated medical reassurance (28). As part of establishing a study on functional somatic 
disorders and related conditions such as health anxiety in the general Danish population, the 
DanFunD study (13), a new brief interview inspired from SCAN was developed: The Research 
Interview for Functional somatic Disorders (RIFD). RIFD introduces a two-step approach where 
self-reported symptom questionnaires are followed by e.g. clinical interviews or clinical 
examination. This has been done in population-based studies including single functional somatic 
disorders such as IBS and FM (29-31) but never in studies including definitions of various 
functional somatic disorders.  
The primary objective of this paper was to present and describe the development and feasibility of 
RIFD. As a secondary objective, we conducted a small preliminary study on the criterion validity 
and interrater reliability in identifying cases with functional somatic disorders and cases with health 
anxiety. 
2. Methods 
2.1. Study population 
A subsample from the Danish Study of Functional Disorders (DanFunD) part II cohort (n=7493) 
was included in the study (Figure 1) (13). Participants answered symptom questionnaires with 
symptom scales for BDS (3) and the Whiteley-7 scale for health anxiety (32) among others. 
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Questionnaire answers formed the basis for a stratified sample of random participants and high 
score participants to be selected for RIFD (n=2450). RIFD was performed parallel with conduction 
of the symptom questionnaires within the period of December 2012 to August 2015.  
In a small preliminary test of the criterion validity and interrater reliability of RIFD, 49 randomly 
selected consecutive RIFD participants were invited to participate in a full face-to-face SCAN 
interview, and 15 randomly selected RIFD interviews were rated simultaneously by at least two 
interviewers.  
Figure 1 about here  
2.2. Instruments 
2.2.1. SCAN 
The modified version of the face-to-face SCAN 2.1 with the 10th edition of the Present State 
Examination (PSE-10) (18) was used. Section two holds a section on physical diseases and 
symptoms, a section on health anxiety, and a section on dissociative or conversion disorders. Based 
on diagnostic algorithms, SCAN can identify, among others, somatoform and dissociative disorders 
and  bodily distress.   
The basic principle in SCAN is the interviewer's assessment of whether or not a symptom or 
symptom pattern is present and which diagnosis can account for this. The semi-structured form 
secures that the interviewer asks for all relevant symptoms, while being free to use any available  
additional information to qualify the judgment regarding  differential diagnostics.  
2.2.2. Research Interview for Functional somatic Disorders (RIFD) 
RIFD is a semi-structured interview designed to be conducted by telephone. It encompasses 
symptoms inspired from the modified SCAN with items for diagnosing a range of functional 
somatic syndromes, i.e. IBS (33), FM (34), CFS (35), BDS (3,36), and health anxiety (28), among 
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others. It also covers anxiety, depression, and somatoform disorders from DSM-IV, DSM-5, and the 
draft of the 11th version of the International Classification of Diseases (ICD-11), which, however, 
are beyond the scope of this paper (Appendix A). During RIFD, the interviewer rates each symptom 
directly in a computer-based programme from where the entered data can be exported and analysed 
as quantitative data. 
As in SCAN, the basic principle in RIFD is the interviewer's assessment of whether or not a 
symptom or symptom pattern is present, the severity of symptoms and impairment, and whether or 
not the participant has another medical condition that may account for their symptoms.   
First, the interviewer is instructed to browse the participant's responses to the symptom 
questionnaires (Appendix B). In case of no health-related troubles, the interviewers are instructed to 
ask "I can see that you have not indicated any symptoms or discomfort in the questionnaire. Does 
that mean that, in the past year, you have not had any physical diseases, symptoms, injuries, pains, 
or other disorders that have limited you in your daily life?". If the participant confirms, the 
interview is ended. If the participant confirms to have symptoms, the interviewer is instructed to ask 
"Have you seen a doctor because of the symptoms? Did he/she find an explanation for them?". The 
interviewer can explore the case by additional questions if deemed necessary. In the beginning of 
the interview, a range of physical conditions are listed to assess whether the participant has one or 
more diseases that could cause any of the symptoms identified later on in the interview.  
Second, functional somatic disorders are assessed. These sections are divided into symptom clusters 
defined by the BDS construct; i.e. cardiopulmonary, gastrointestinal, musculoskeletal, and general 
symptoms clusters (3). In addition, other symptoms are briefly assessed such as genital problems, 
MCS (37,38), WAD (39), and conversion/dissociative disorders. The symptoms listed in each 
cluster are largely identical with the corresponding symptoms in the questionnaires, and the 
interviewer can use the participant's answers from the questionnaires as a base for the interview. For 
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each symptom cluster, the interviewer, depending on the participant's questionnaire answers, asks: 
If negative response to e.g. musculoskeletal symptoms: "According to the questionnaire, you have 
not had any musculoskeletal problems in the past year. Have I understood this correctly?" If this is 
confirmed, the interviewer moves on to the next symptom cluster. If positive response: "In the 
questionnaire, you have indicated that you have suffered from (the symptoms indicated in the 
questionnaire are mentioned) within the past year. What is that about?" The interviewer can further 
explore the complaints if deemed necessary and register the positive symptoms in the interview.  
After each section of symptom clusters, the interviewer assesses whether the symptoms are 
attributed to a conventionally-defined physical disease such as cancer or rheumatoid arthritis.  
Finally, the interviewer assesses how impaired the participant is due to the symptoms. This is done 
by one item stating "How much have the mentioned symptoms all in all disturbed your regular daily 
activities?". The item is scored on a four-point Likert scale with options "Not at all", "Only small 
impact or discomfort", "Moderate or intermittent impact or discomfort", "Severe or incapacitating 
impact or discomfort", and it also includes the option "Uncertain/unknown/don't now". 
In the next section, health anxiety is assessed. As diagnostic aid, the interviewer has access to the 
participant's answers from the symptom questionnaires, but the symptoms asked for in the RIFD 
stem from the original version of the modified SCAN (18). 
Hereafter follow the sections for major depressive disorder and anxiety disorders. The interviewer is 
aided by the Symptom Checklist-90 (SCL-90) depression and anxiety subscales (40). Only 
symptoms included in the diagnostic criteria (ICD-10 and DSM-IV) for depression and anxiety are 
explored (41). The anxiety section encompasses single items concerning generalised anxiety, panic 
attacks, agoraphobia, and social anxiety.  
Finally, the participants are asked if they have another mental disorder not already identified. 
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2.3. RIFD procedure  
All RIFDs were conducted telephonically by three family physicians, all with at least 12 years of 
practise in family medicine and trained in both RIFD and SCAN. During two meetings, the 
interviewers were introduced to RIFD, and they pilot-tested the interview procedure on two study 
participants.  
The interviewers were seated at The Research Clinic for Functional Disorders and Psychosomatics 
at Aarhus University Hospital, Denmark, and they could get supervision from other physicians and 
specialists at the clinic or, if necessary, ask any medical specialist at Aarhus University Hospital. 
Hence, during the interview period, continued clinical education and supervision took place. 
The interviewees were seated in their own homes in the Western part of Copenhagen.  
Each participant was given two time slots where the interviewer could contact them, and they 
further received a contact number to a secretary if they were hindered during  the assigned times. If 
so, they were assigned a new time for the interview.  
Sixty minutes were allotted for each interview and if exceeded, the next participant was allocated 
the next time slot he/she had been given. This could be the case if a participant had numerous 
symptoms and complaints which required a more thorough assessment.  
Feasibility and acceptance of RIFD was assessed by independent unstructured interviews with the 
three interviewers.  
2.4. Comparison of cases and non-cases 
Data from the symptom questionnaires were used to investigate differences between identified 
individuals with a functional somatic disorder or health anxiety and individuals without these 
disorders. Self-perceived health and limitations in daily activities were obtained through single 
items from the 12-item Short Form Health Survey (42). Presence of physical and mental comorbid 
conditions was obtained through a list of 17 conventionally-defined conditions such as cancer, 
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myocardial infarction, asthma, and diabetes and two mental disorders; depression and anxiety (10). 
Difference in scores for health anxiety was measured on the 7-item Whiteley Index (32), 
normalized to a 0-100 scale. 
2.5. Preliminary test of psychometric properties 
 
For considering criterion validity, a random selection of participants for the SCAN interview went 
on during three time periods during the three-year period where RIFD was conducted. Individuals 
agreeing to participate in SCAN received a time to meet at the Center for Clinical Research and 
Prevention, the Capital Region, for the interview. A psychiatrist and family medicine specialist with 
great experience in SCAN was responsible for conducting the interviews. She had no knowledge of 
the answers given by the participants in neither the symptom questionnaires nor RIFD. Two hours 
were assigned for each SCAN interview.  
For measuring interrater reliability, RIFDs were consecutively rated by two or three raters as 
follows: One interview in January 2014, ten interviews in July 2014, and four interviews in April 
2015. For each test, the raters were located in separate rooms during the interview. One of the raters 
conducted the interview, while the other raters overheard the interview and made their own 
assessment at the same time.  
In each case, the participants were informed about the procedure and gave their consent for their 
interview to be overheard by several raters. 
2.6. Statistical analysis  
All analyses were performed in Stata 15.0 for Windows (StataCorp LLC, College Station, USA). 
Difference in prevalence of functional somatic disorders and health anxiety between SCAN and 
RIFD was evaluated with McNemar's test for paired binominal data. Identified cases were 
compared to non-cases regarding different self-reported covariates from the symptom 
ACCEPTED MANUSCRIPT
AC
C
EP
TE
D
 M
AN
U
SC
R
IP
T
 
questionnaires such as sex, poor self-perceived health, limitation in daily activities, and 
comorbidity. Relative risks were calculated with generalized linear models with binominal family 
and log link. For criterion validity, unweighted Kappa coefficients were calculated with 95% 
confidence intervals (CI) for the assignment of participants into cases and non-cases of functional 
somatic disorders and health anxiety. Sensitivity, specificity, positive predictive value (PPV), and 
negative predicted value (NPV) were also calculated with 95% CI. Interrater reliability was 
measured and interpreted with unweighted Kappa coefficients with 95% CI. Landis and Koch's 
division into classes of agreement was used for interpretation of both criterion validity and interrater 
reliability (43): 0.0–0.20, slight agreement; 0.21-0.40, fair agreement; 0.41–0.60, moderate 
agreement; 0.61–0.80, substantial agreement; 0.81–1.00, near perfect agreement. 
 
2.7. Ethical considerations 
 
Written informed consent was obtained from each participant before participation. The study was 
approved by the Ethical Committee of Copenhagen County (Ethics Committee: KA-2006-0011; H-
3-2011-081; H-3-2012-0015) and the Danish Data Protection Agency (Jnl No.: 2012-58-006). 
 
3. Results 
The final sample of RIFD participants consisted of 1590 (64.9%)  individuals with a median age of 
54 years (Interquartile range (IQR: 44-63); 942 (59.3%) were women. Most of them (67.9%) had 
more than three years of vocational training and most of them were currently employed (63.5%).  
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3.1. Feasibility of RIFD 
All three interviewers revealed the interview to be feasible to conduct. It was easy to get hold of the 
participants, i.e. in less than 20 cases, the interviewers could not get through to the participants. 
When initiated, all interviews were carried out without any dropouts indicating a good adherence to 
the procedure and acceptability of the interview.  
In general, completion of each interview varied from five minutes for participants with no 
symptoms or complaints to 45 minutes for participants with multiple symptoms and complaints (a 
few participants with heavy symptom loads deviated with interviews lasting well over an hour). 
Preparation time for RIFD was 5-10 minutes to go through the symptom questionnaires. 
Very few interviews revealed problems requiring the interviewer to intervene for ethical reasons: 
One case had serious alcohol abuse and revealed suicidal intentions during the interview. Other 
interviews revealed clear suspicion of serious disease, e.g. undiscovered cancer and ischemic heart 
disease. In these cases, the interviewers contacted the participants' general practitioner, with the 
participants' permission, and secured the further course. These participants were not excluded from 
the study.   
The interviewers reported to have good contact with the participants and felt a trust on the 
participants' part that allowed for confiding their symptoms and complaints similar to a face-to-face 
consultation. 
Participants were satisfied with the interview and showed great interest in talking about their health 
and symptoms. Neither the interviewers nor the DanFunD study contact personnel received 
complaints from the participants, and there were no reports on interviews ending in a bad manner, 
i.e. discussion or dissatisfaction.   
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3.2. Characteristics of cases from the RIFD interview 
RIFD identified individuals with functional somatic disorders or health anxiety that differed 
significantly from individuals without these disorders (Table 1). Cases of functional somatic 
disorders were more often women, and they had significantly higher risk of having a poor self-
perceived health, limitations in daily activities, and comorbid physical and mental disease. Cases of 
health anxiety were also more often women, had higher risk of mental comorbidity, and scored 
significantly higher on the Whiteley-7 scale for health anxiety. 
Table 1 about here 
 3.3. Preliminary test of psychometric properties  
Of the 49 participants invited to a SCAN interview, 38 (77.5%) agreed to participate, and a total of 
25 (51.0%) full SCAN interviews were completed (Figure 1). 
It took around 25 minutes to complete a SCAN interview for participants with no notable symptoms 
and around two hours for a participant with many symptoms. No differences in prevalence of 
functional somatic disorders (p=0.29) and health anxiety (p>0.99) between RIFD and SCAN were 
seen (Table 2). 
 
Table 2 about here 
With regard to criterion validity, a fair agreement was seen for functional somatic disorders, and a 
moderate agreement was seen for health anxiety (Table 3).  
As to interrater analysis, 13 participants were rated by three raters, and two were rated by two 
raters. The interrater agreement for functional somatic disorders was moderate (ĸ=0.47, 95% CI, 
0.10-0.77), while it was near perfect (ĸ=0.83, 95% CI 0.31-0.97) for health anxiety.  
Table 3 about here 
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3.2.1. Discrepancies between RIFD and SCAN 
Discrepancy between RIFD and SCAN was caused by eight cases of RIFD false negatives and three 
cases of RIFD false positives (Table 4). The false negatives were caused by 1) symptoms identified 
in SCAN but not in RIFD, or 2) symptoms identified in both interviews but assessed to be caused 
by a conventionally-defined disease in RIFD. The false positives were caused by RIFD reporting 
higher number or more impairing symptoms than SCAN. 
 
Table 4 around here 
4. Discussion 
4.1. Principal findings 
This paper presents the newly developed RIFD and reports results on its feasibility and acceptance. 
To our knowledge, RIFD is the first brief, clinical research interview for functional somatic 
disorders and health anxiety for use in large epidemiological studies. The study showed that RIFD 
was feasible to perform and well accepted by both interviewees and interviewers. RIFD identified 
cases that differed significantly from non-cases on different covariates, indicating poorer life 
quality. The RIFD also showed promising criterion validity and interrater reliability in a small 
preliminary test.  
4.2. Discrepancies between RIFD and SCAN 
Discrepancies between RIFD and SCAN may be caused by the complicated nature of functional 
somatic disorders making it difficult to differentiate them from comorbid disease.  
Also, the difference in the interviewers' background, "culture" within medical specialty, and 
understanding of disease could induce rater bias (44). Besides being a specialist in primary care and 
psychiatry, the SCAN interviewer had long-time experience conducting SCAN on heavily 
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invalidated patients with multiple functional somatic disorders in a highly specialized setting. In 
that setting, the presence of one or two conventionally-defined physical diseases would not explain 
the patient's whole symptom pattern, hence, they would still be assessed to have a functional 
somatic disorder. The SCAN interviewer might have overstated the presence and severity of 
symptoms in this population-based (and therefore presumably less impaired) sample, 
overdiagnosing functional somatic disorders. On the other hand, the RIFD interviewers were 
specialists within family medicine with large experience from primary care dealing with patients 
presenting with unexplained and presumably less incapacitating symptoms. They did not have the 
routine of assigning diagnoses of functional somatic disorders, and they may tend to rate more 
conservatively giving diagnoses of conventionally-defined disease as reason for symptom patterns. 
However, since all RIFD interviewers were also SCAN trained, it is reasonable to assume that the 
interviewers' basic understanding of establishing diagnoses of functional somatic disorders and 
health anxiety was adequate for this study's purpose. Also, when SCAN is used for diagnosing at 
the Research Clinic for Functional Disorders and Psychosomatics, every interview is conducted 
following a review of the patient's medical records and self-report on symptom questionnaires; an 
approach largely resembling the RIFD procedure in this study. However, the SCAN interviews in 
this study were conducted with the SCAN interviewer having no knowledge about the participant's 
symptom questionnaires, medical records, or other preparatory information. The different 
preparatory material might also have influenced on the shown discrepancies. 
4.3. Comparison with other studies 
4.3.1. Feasibility and criterion validity 
Other comparison studies on shorter diagnostic interviews and SCAN have been performed, but 
they focused on ICD-10 psychiatric diagnoses. Concerning feasibility, studies report short form 
interviews to be acceptable and feasible compared to SCAN (26,45,46). However, in one of the 
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studies, the interviewer reported suspicion about the interviewees having problems understanding 
the wording in some parts of the short form interview (45) contrary to our study, where unstructured 
interviews with the three RIFD interviewers revealed all parts of RIFD to be understandable and 
manageable to go through for both interviewers and interviewees. Population-based studies found 
measures of agreement consistent with this study when comparing the Composite International 
Diagnostic Interview (CIDI) (47), the Diagnostic Interview Schedule (DIS) (12), and the Clinical 
Interview Schedule Revised (CIS-R) (45) with SCAN ICD-10 psychiatric diagnoses.  
Studies including patient samples also find results comparable with ours: One used public health 
doctors as interviewers when comparing CIDI and CIS-R with SCAN ICD-10 neurotic disorders 
given by a SCAN trained psychiatrist (48), and another compared the shortened version of SCAN 
with SCAN (26) obtaining very good agreement in almost all diagnostic categories.  
4.3.2. Face-to-face interviews vs. telephone interviews 
In all the above mentioned studies, interviews were conducted as face-to-face interviews as opposed 
to our study, where only SCAN was conducted face-to-face and RIFD was performed over 
telephone. This might have influenced the obtained agreement and raise the question if telephone 
interviews are just as valid as diagnostic face-to-face interviews. A review reported insufficient 
evidence for telephone-conducted diagnostic interviews being as valid as face-to-face diagnostic 
interviews (49). However, since we reported properties regarding criterion validity comparable with 
other studies, we assume that this issue has minor influence.  
4.3.3. Studies within other medical fields 
Within neurology and pain research, diagnostic research interviews have shown to be beneficial. 
Studies in migraine have shown similar results of interview agreement as in our study (50,51), and a 
headache study points out that diagnostic interviews are superior in assigning correct diagnoses 
when comparing to questionnaires alone (52). Also, one study showed interviews to be even more 
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precise and accurate when used in combination with a self-reported headache diary (53) which 
supports the use of symptom questionnaires before RIFD.  
 
4.4. Strengths and limitations  
This study has several strengths. First, the large sample of 1590 participants is a major strength 
giving high power in the comparison analyses of cases and non-cases. Second, the participants were 
sampled from an unbiased general population sample in contrary to patients from more selected 
clinical samples. Third, the study's two-phase design secured a more cost-effective and targeted 
procedure where only relevant participants were identified for RIFD. In this study, specific 
symptom scales were used in the questionnaires, but since the purpose of the questionnaires is to 
establish an overview of the participants' symptoms, future studies may not have to use the exact 
same symptom scales. Furthermore, since family physicians in general are unsure of how to 
diagnose and examine patients for functional somatic disorders, the two-step approach using the 
combined technique of symptom questionnaires and interviews may pave the way for improved 
diagnostics by non-specialists.  
However, the results from this study also have to be seen in the light of some study limitations. 
First, the participation rate in RIFD was only 64.9%, but since the flow of RIFD participants 
increased during the recruitment period, the participation rate was more likely to be caused by the 
recruitment method and not the RIFD interview itself. Second, the majority (92.5%) of the RIFD 
decliners constituted high scores on the symptom questionnaires. Two-phase designs have the 
general limitation of losing some of the phase one participants in the second phase (54), and it 
would be reasonable to assume that these participants had a higher burden of symptoms than 
completers. We therefore believe this limitation to be linked to the overall study design more than 
to RIFD itself. Third, the workload and time spent on performing SCAN interviews and interrater 
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reliability tests carry important limitations in the form of small study samples causing low power to 
the statistical analyses. A final but important limitation is that no participants were further examined 
with diagnostic or paraclinical tests. Hence, from this study, we cannot conclusively determine 
which interview was correct in the cases of discrepancies, but it is clear that these discrepancies 
emerged because of different assessments of whether or not conventionally-defined disease caused 
the symptoms. Doing further clinical examinations would be the final step in clarifying this and 
getting closer to a "true" diagnosis. 
  
5. Conclusion 
Compared to SCAN, RIFD was feasible and affordable to conduct. It was a promising tool for 
identifying cases of functional somatic disorders and health anxiety in large epidemiological 
studies. A small preliminary test on some of its psychometric properties showed fair to near perfect 
agreement. Further studies are needed on RIFD before using it as a standard tool for assessing 
functional somatic disorders and health anxiety in large epidemiological studies.  
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Figure legends  
Figure 1: Flowchart. Flow of participants ' inclusion in the DanFunD study, procedure of establishing a stratified 
subsample for the Research Interview for Functional somatic Disorders (RIFD), and selection of participants for testing 
criterion validity and interrater reliability. Randomly selected=one tenths of all consecutive participants from the self-
reported symptom questionnaires; High scores=all cases of bodily distress syndrome (3) or health anxiety (32) from the 
self-reported symptom questionnaires. SCAN=Schedules of Clinical Assessment in Neuropsychiatry  
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Tables 
Table 1 
 FSD HA 
 N=435 N=99 
   
Sex; Women vs. men, RR (95% CI) 1.3 (1.2-1.4) 1.2 (1.1-1.4) 
   
Poor self-perceived health
a
, RR (95% CI) 2.5 (2.1-3.0) 1.3 (0.9-1.8) 
   
Limitations in daily activities
a
, RR (95% CI) 2.2 (1.9-2.6) 1.0 (0.7-1.4) 
   
Mental comorbidity, RR (95% CI) 2.1 (1.8-2.5) 2.0 (1.5-2.5) 
   
Physical comorbidity, RR (95% CI) 1.1 (1.0-1.1) 1.0 (0.9-1.1) 
   
Whiteley-7 score difference
b
 (0-100) (95% CI)  13.5 (11.3-15.7) 29.5 (25.4-33.5) 
   
   
Table  1: Characteristics of cases of functional somatic disorders (FSD) and health anxiety (HA) compared to non-cases. 
a
Single items from  the 12-
item Short Form Health Survey (12). 
b
(32). RR=relative risk; CI=confidence interval. Bold: Significantly different from non-cases (p<0.05). Number 
of FSD non-cases=1150. Number of HA non-cases=1491. Total N=1590. 
 
Table 2 
 Concordance SCAN/RIFD Prevalence  
 
Both interviews 
negative (n) 
O nly RIFD 
positive (n) 
O nly SCAN 
positive (n) 
Both interviews 
positive (n) 
SCAN RIFD 
 -/- -/+ +/- +/+ % (95% CI) % (95% CI) 
       
Functional somatic 
disorders 
9 2 6 8 
56.0 
(34.9-75.6) 
40.0
○
 
(21.1-61.3) 
       
Health anxiety 19 1 2 3 
20.0 
(6.8-40.7) 
16.0
◊
 
(4.5-36.1) 
       
Table  2: Concordance between Schedules of Clinical Assessment in Neuropsychiatry (SCAN) and the Research Interview for Functional somatic 
Disorders (RIFD). Functional somatic disorders: Bodily distress syndrome or functional somatic syndrome. CI=confidence interval. No significant 
differences in prevalences between SCAN and the RIFD interview (
○
p=0.29. 
◊
p>0.99). N=25 
 
Table 3 
 
O bserved agreement 
% (95% CI) 
Cohen's Kappa 
(95% CI) 
Sensitivity 
% (95% CI) 
Specificity 
% (95% CI) 
PPV 
% (95% CI) 
NPV 
% (95% CI) 
       
Functional somatic 
disorders 
68.0  
(46.5-85.1) 
0.38  
(-0.03-0.7) 
57.1  
(28.9-82.3) 
81.8  
(48.2-97.7) 
80.0  
(44.4-97.5) 
60.0  
(32.3-83.7) 
       
Health anxiety 
88.0  
(68.8-97.5) 
0.59  
(0.1-0.9) 
60.0  
(14.7-94.7) 
95.0  
(75.1-99.9) 
75.0  
(19.4-99.4) 
90.5  
(69.6-98.8) 
       
Table  3: Criterion validity of the Research Interview for Functional Somatic Disorders using Schedules of Clinical Assessment in Neuropsychiatry as 
gold standard. Functional somatic disorders: Bodily distress syndrome or functional somatic syndrome; PPV=positive p redictive value; 
NPG=negative predictive value; CI=confidence interval. N=25  
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Table 4 
  
 Discrepancies between interviews on functional somatic disorders 
  
Discrepancy 
N 
participants 
SCAN 
outcome 
RIFD 
outcome 
Notes 
 
    
RIFD  
false-positive 
2 - + 
Both interviews report symptoms but in SCAN they are stated to be caused by 
conventionally-defined organic disease. Hence, the participants were identified as 
non-case in SCAN 
 
    
 
    
RIFD  
false-negative 
2 + - 
RIFD does not report sufficient number or severity of symptoms to fulfill any 
criteria of functional somatic disorder. Hence, the participants were identified as 
non-case in RIFD 
 
4 + - 
RIFD does not report sufficient number or severity of symptoms to fulfill any 
criteria of functional somatic disorder and reported symptoms were assessed as 
having conventionally-defined organic disease as cause. Hence, the participants 
were identified as non-case in RIFD 
 
    
  
 Discrepancies between interviews on health anxiety 
  
Discrepancy 
N 
participants 
SCAN 
outcome 
RIFD 
outcome 
Notes 
 
    
RIFD  
false-positive 
1 - + 
RIFD reports sufficient number and severity of symptoms enough for fulfilling 
criteria of health anxiety but this was not the case in SCAN 
 
    
RIFD  
false-negative 
2 + - 
RIFD does not report any symptoms. In SCAN, some mild symptoms of health 
anxiety are reported 
 
    
Table  4: Description of participants with discrepancy in outcome between Schedules of Clinical Assessment in Neuropsychiatry (SCAN) an d the 
Research Interview for Functional somatic Disorders (RIFD). Outcome=non-case (-) or case (+). N=25 
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Highlights 
 
 RIFD assesses functional somatic disorders and health anxiety  
 RIFD was feasible and affordable to perform in a large population-based study 
 RIFD was well accepted by both interviewers and interviewees 
 RIFD clearly identified cases with poorer health and quality of life than non-cases 
 RIFD showed promising psychometric properties, but larger studies are needed 
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